• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Haematol . Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19

tetano

Editor, Senior Moderator
Eur J Haematol


. 2020 Aug 13.
doi: 10.1111/ejh.13509. Online ahead of print.
Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19


Irene Pakos[SUP] 1 [/SUP], Kevin Bryan Lo[SUP] 1 [/SUP], Grace Salacup[SUP] 1 [/SUP], Jerald Pelayo[SUP] 1 [/SUP], Ruchika Bhargav[SUP] 1 [/SUP], Eric Peterson[SUP] 1 [/SUP], Fahad Gul[SUP] 1 [/SUP], Robert DeJoy 3rd[SUP] 1 [/SUP], Jeri Albano[SUP] 1 [/SUP], Gabriel Patarroyo-Aponte[SUP] 2 3 [/SUP], Janani Rangaswami[SUP] 1 3 [/SUP], Zurab Azmaiparashvili[SUP] 1 [/SUP]



Affiliations

Abstract

Background: A lot remains unknown about the features and laboratory findings that may predict worse outcomes in patients with Coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the difference in complete blood count parameters and differential counts in patients hospitalized with COVID-19 who survived compared to those who died.
Design: We performed a single center retrospective study including 242 patients with confirmed COVID-19. We described the characteristics of the complete blood count parameters in these patients. Mann Whitney-U test was used to compare hematologic parameters of patients who died and those who survived; multivariate logistic regression was used to look for associations with mortality.
Results: Patients with COVID-19 who died had significantly lower median absolute monocyte count (AMC) (0.4 vs 0.5, p=0.039) and median platelet count (169 vs 213, p=0.009) compared to those who survived. Patients who died had a significantly higher neutrophil to lymphocyte ratio (6.4 vs 4.5, p = 0.001). The NLR was positively associated with death (OR=1.038; 95% CI, 1.003 to 1.074, p=0.031) while AMC was inversely associated with death (OR=0.200; 95% CI, 0.052 to 0.761, p=0.018).
Conclusion: Among patients with COVID-19, a lower AMC and higher NLR are associated with higher mortality.

Keywords: COVID-19; lymphopenia; monocytes; novel coronavirus.
 
Back
Top Bottom